arsenic trioxide has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiforeanu, DC; De Latour, B; Duclos, M; Gutierrez, FL; Joannes, A; Jouneau, S; Le Naoures, C; Morzadec, C; Rouzé, S; Vernhet, L; Wollin, L | 1 |
1 other study(ies) available for arsenic trioxide and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Topics: Arsenic Trioxide; Becaplermin; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Lung; NF-E2-Related Factor 2; Transforming Growth Factor beta1 | 2022 |